Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

By F. Marty, L. Ostrosky-Zeichner, O. Cornely, K. Mullane, J. Perfect, G. Thompson, G. Alangaden, Janice M. Y. Brown, David N. Fredricks, W. Heinz and 24 more. Lancet. Infectious Diseases (Print), 2016

607 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/073d21894a9c87b625bf6941394732f9e73de465

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. H. Prakash

Citations in the corpus

• Global Epidemiology of Mucormycosis (2019, background): “, 2016 reported an increased frequency of mucormycosis cases after treatment with voriconazole prophylaxis in HSCT patients [92].”